06 October 2022
Optos has reported record group revenues for 2022, in what is the company’s 30th anniversary year.
The company has seen a 14% annual revenue growth for the year ended March 2022, resulting in record group revenues of $254m (approx. £277m).
Optos also celebrated a new milestone with its imaging platforms, as it has surpassed more than 22,000 installations of its devices worldwide.
Douglas Anderson founded Optos in 1992 after his five-year old son lost his sight in one eye due to a retinal detachment, despite having had regular eye examinations. Optos began with the goal of designing a device to capture an ultra-widefield image of the retina.
Since launching, the business has continued to invest in research and development (R&D), amounting to $18.6m (£15m) for the year ended March 2022. This is up 40% on the previous year.
Optos’ most recent launch is an ultra-widefield AI, which facilitates the early detection and management of diabetic retinopathy. The device received CE-mark in spring 2022.
Rob Kennedy, CEO of Optos, said: “We are proud of what Optos has achieved over the past three decades,” adding that the company has remained “true” to the founders’ core purpose of improving patient outcomes through imaging technology and reducing the risk of sight loss.
“We have delivered significant growth, continue to develop our technology, and ultimately enabled our customers to help save the sight of their patients,” he said.
Optos employs over 500 people in roles across R&D, manufacturing, clinical research and sales.
“I want to thank all the Optos team for their innovation and hard work over the last 30 years. It’s this dedication and commitment that has helped shape Optos to become the business it is today and we look forward to continuing to push the boundaries in support of our customers and their patients,” Kennedy concluded.
More than 2000 published and ongoing clinical trials have been conducted, the company shared, adding that “thousands” of case studies support the value of Optos’ optomap imaging and optical coherence tomography.
Comments (0)
You must be logged in to join the discussion. Log in